Katharine Peterson
Vice President of Finance & AccountingMs. Katharine Peterson, also known as Katie, C.P.A., serves as Vice President of Finance & Accounting at Acrivon Therapeutics, Inc. After beginning her career in the life sciences assurance practice at EY, she has helped multiple small biotech companies with public company readiness and IPO-directed efforts. She has over a decade of experience in the biotechnology industry, working on financial management, operations, technical accounting, reporting, and planning. Prior to joining Acrivon, she was Senior Director of Financial Planning & Analysis at Wave Life Sciences, and held various roles within both Spero Therapeutics and Merrimack Pharmaceuticals. She holds a BA in Business Economics form Providence College, an MS in Accountancy from the University of Notre Dame, and is a Certified Public Accountant (CPA) in the state of Massachusetts.
Positions
- Company NameAcrivon Therapeutics, Inc.Stock CodeACRVPositionVice President of Finance & AccountingColleagues
- PBPeter Blume-JensenCo-Founder, Chairman of the Board, CEO, President & Acting Chief Scientific Officer
- KMKristina MassonCo-Founder, Executive VP of Business Operations, Site Head, Treasurer & Director
- EJEric J. DevroeChief Operating Officer
- ADAdam D. LevyCFO & Principal Financial Officer
- JVJesper V. OlsenAcademic Co-Founder, Head of Phosphoproteomics & Member of Scientific Advisory Board
- MJMichael John TomsicekIndependent Director
- CMCharles M. BaumIndependent Director
